Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively... por Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K

Enlace del recurso

Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib por Fautrel, B, Taylor, P, Michaud, K, Patel, H, Zhu, B, Gaich, C, Guo, J, Quebe, A, Tanaka, Y

Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis por Michaud, K, Pope, J, van de Laar, M, Curtis, JR, Kannowski, C, Mitchell, S, Bell, J, Workman, J, Paik, J, Cardoso, A, Taylor, PC